Related content

Numerical Analysis of Blood Damage Potential of the HeartMate II and HeartWare HVAD Rotary Blood Pumps

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 8, 2015-08 ,pp. : 651-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exercise Capacity and Functional Performance in Heart Failure Patients Supported by a Left Ventricular Assist Device at Discharge From Inpatient Rehabilitation

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 1, 2018-01 ,pp. : 22-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status of Left Ventricular Assist Devices and Cell Sheet Engineering for Treatment of Severe Heart Disease in Japan

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 7, 2015-07 ,pp. : 543-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utilizing Right Ventricular Assist Device With Extracorporeal Membrane Oxygenator for Management of Diffuse Alveolar Damage After Orthotopic Heart Transplant

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 3, 2015-03 ,pp. : 289-291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Third Generation Ventricular Assist Device: Mid‐Term Outcomes of the HeartWare HVAD in Pediatric Patients

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 2, 2018-02 ,pp. : 141-147

John Wiley & Sons Inc

Access to resources Recommend Favorite